High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.
about
Fibrates for secondary prevention of cardiovascular disease and strokeDietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemiaFibrates for secondary prevention of cardiovascular disease and strokeDietary treatment for familial hypercholesterolaemiaEffect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out miceHemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoproteinFunctional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-IIA-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian familyA phospholipidomic analysis of all defined human plasma lipoproteinsTherapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studiesHigh-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and AtherosclerosisHigh density lipoprotein and metabolic disease: Potential benefits of restoring its functional propertiesEndothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular DiseaseDysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsIs higher serum cholesterol associated with altered tendon structure or tendon pain? A systematic reviewHDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosisAdvances in the Study of the Antiatherogenic Function and Novel Therapies for HDLNew drugs for treating dyslipidemia: beyond statinsMitochondrial function and regulation of macrophage sterol metabolism and inflammatory responsesCardioprotective functions of HDLsAtheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P)Statins in cardiometabolic disease: what makes pitavastatin different?Cholesterol crystals and inflammationA low-carbohydrate high-fat diet increases weight gain and does not improve glucose tolerance, insulin secretion or β-cell mass in NZO mice.Insights into the Tunnel Mechanism of Cholesteryl Ester Transfer Protein through All-atom Molecular Dynamics SimulationsProlonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses.The prevention and regression of atherosclerotic plaques: emerging treatments.A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport.Action mechanism and cardiovascular effect of anthocyanins: a systematic review of animal and human studiesRole of oxidized lipids in pulmonary arterial hypertensionA century of cholesterol and coronaries: from plaques to genes to statinsWill Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?Niacin Therapy, HDL Cholesterol, and Cardiovascular Disease: Is the HDL Hypothesis Defunct?Novel methodologies for biomarker discovery in atherosclerosisEffect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patientsFenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemiaDescription of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of actionJTT-705: is there still future for a CETP inhibitor after torcetrapib?The therapeutic role of niacin in dyslipidemia managementTranscriptional regulation of the human hepatic lipase (LIPC) gene promoter
P2860
Q24186376-E5BB6C1B-8155-4E01-BFDE-61F24CE763BCQ24194060-69EEB9D8-E218-477A-BCBB-A6CBB06B0D3FQ24204000-F8EAD279-FF9C-427E-BD2F-B0C2D55DB12DQ24240324-28DDD76A-6F01-4390-8C7F-54A25D863B96Q24300591-0384EB99-D8CE-41EC-992E-83B97F9B170FQ24309793-1194C004-E60A-4943-B385-605CF1711E98Q24312351-216507F7-A540-442A-A7BD-995C93D1EDC5Q24597463-02F4B1FA-74FA-4822-89E8-472BE2A519ACQ24627736-02AD3DB3-F865-4B46-9353-8BDC436D926EQ26738588-99007A19-507A-41B1-B1F0-264E99A32233Q26746080-FD7369D5-331E-4D17-8547-0E4536923606Q26750603-EE75F64F-35F4-4F31-A2CD-02ECE6326271Q26770056-4D77EED2-AAC9-4663-A648-8E608EE83C89Q26774903-1EFBB277-AFF0-41D5-9EE5-94EEC7417916Q26782221-69B9AAE1-B31D-4F6E-96DC-D290ED47E535Q26782972-89F41C7F-DF54-4DA6-B8F3-D26E28B02DC2Q26801507-6D96B401-54F8-461F-B522-11CAA024423BQ26821840-0EC9E274-737D-4A1D-98EE-2CEBCCD50566Q26825337-F8871EA6-F26C-4838-8812-D9E7C5DBB2BFQ27000421-1CCF9799-132C-4D11-93CB-11C600DF7817Q27000801-3950CDC2-CBCB-41AA-A460-C75866BBAA4DQ27010638-0E4FB3D0-BADC-45AD-AC3B-F3E8B17D7276Q27024737-E9F30EC6-65C7-41D2-B058-FFB6516537B7Q27310129-1A38D64D-93C9-42C3-95E8-2EA7CFE2AFDFQ27312096-882CB3E9-B97D-4B8A-B49D-767CD28AC896Q27319844-CA4EB8AB-F9D8-4979-8F66-32D06CCFF1D6Q27691367-B42198CA-8306-408C-8138-A3E509CC17A7Q27693251-49363F5C-4008-4F39-879A-4C972BFA9B0FQ28077812-1C70EF6B-8859-49A4-88DC-E65CD804B91EQ28078566-B5714152-D633-452F-8C69-7F14CE5B7B9CQ28080618-2C73C846-B717-459D-9F37-5DA0AACEA067Q28080768-BF8F605D-94F1-453F-8655-2105272D23ECQ28086787-668AE785-8629-4752-9A11-4A3AD4299D13Q28088373-86F8995A-2908-4E66-BC12-58399B2E0F03Q28244205-A397E72E-28A7-4F0D-9984-C076287BDAD4Q28284661-47663CD6-0429-4AFB-8169-9E32D225833AQ28285064-4D07B33B-8149-462E-8341-4520B7C90D42Q28294797-C6520639-0B6F-4C66-A3FA-6C2BFE61FAC0Q28304559-56219186-F1D8-443A-A4E1-8D27320B263AQ28306414-1037E434-D6FE-4544-8F92-8923091FC360
P2860
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
High density lipoprotein as a ...... disease. The Framingham Study.
@en
type
label
High density lipoprotein as a ...... disease. The Framingham Study.
@en
prefLabel
High density lipoprotein as a ...... disease. The Framingham Study.
@en
P2093
P1476
High density lipoprotein as a ...... disease. The Framingham Study.
@en
P2093
M C Hjortland
T R Dawber
W B Kannel
W P Castelli
P304
P356
10.1016/0002-9343(77)90874-9
P407
P577
1977-05-01T00:00:00Z